Flourish Research Expands with New Acquisitions in North Carolina and Alabama
Flourish Research announces the acquisition of two companies, AMC Research in Charlotte, North Carolina, and Central Research Associates (CRA) in Birmingham, Alabama.
NEW YORK, June 1, 2023 /PRNewswire-PRWeb/ -- Flourish Research announces the acquisition of two companies, AMC Research in Charlotte, North Carolina, and Central Research Associates (CRA) in Birmingham, Alabama. AMC is a therapeutically focused Alzheimer's Disease research site and CRA is a multi-therapeutic site. Both acquisitions complement Flourish's strategy of acquiring and integrating best-in-class sites.
Reza Bolouri, MD, is a board-certified neurologist and founder of AMC. Dr. Bolouri has been key to AMC's success with more than 20 years of clinical research experience in Alzheimer's and related dementias. AMC provides Flourish with additional scale in its existing Alzheimer's Center of Excellence and access to a new and densely patient-populated market in Charlotte, North Carolina.
"Through this partnership, we can add value to the Flourish platform by augmenting their already existing Alzheimer's capabilities," Dr. Bolouri said.
CRA, founded in 2016 by William Whitley, PharmD, conducts Phase II-IV clinical trials across various therapeutic areas. The site is located on the campus of St. Vincent's Hospital in Birmingham, Alabama. CRA is a leading national enroller in vaccine studies. CRA will provide Flourish with additional scale in cardiometabolic, pediatrics, orthopedics, and women's health capabilities.
"My team and I are thrilled to have the opportunity to partner with Flourish Research," Dr. Whitley said. "We look forward to working with the team at Flourish and the growth that we can achieve together in the future."
Reinhold Schulz, CEO of Flourish Research, said "We are confident that both AMC and CRA will be great additions to our growing organization. Both partnerships will augment our existing capabilities and allow us to expand into new markets as we continue our journey to become a leader in clinical site services with a focus on diverse and underserved patient populations."
Flourish Research is a leading clinical trial organization, created to strategically acquire, integrate, and operate the best clinical trial sites in North America. Flourish started as some of the most recognized trial sites in the industry. The wholly owned, fully integrated company has locations in Alabama, Florida, Illinois, North Carolina, Pennsylvania, and Texas. Flourish sites conduct Phase I-IV studies across therapeutic areas where they have deep expertise in Cardiology/Metabolic Disease, CNS, and Vaccines.
Cindi Heckmann, Flourish Research, 1 2108541614, email@example.com
SOURCE Flourish Research
Upcoming Life Sciences Events
- September 2023
- Barcelona: BioSpain 2023
- October 2023
- New York City: BioFuture
Latest company news
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China